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Abstract
Background: PINK1 is a mitochondria-targeted kinase that constitutively localizes to both the mitochondria and
the cytosol. The mechanism of how PINK1 achieves cytosolic localization following mitochondrial processing
remains unknown. Understanding PINK1 subcellular localization will give us insights into PINK1 functions and how
mutations in PINK1 lead to Parkinson’s disease. We asked how the mitochondrial localization signal, the
transmembrane domain, and the kinase domain participate in PINK1 localization.
Results: We confirmed that PINK1 mitochondrial targeting signal is responsible for mitochondrial localization. Once
inside the mitochondria, we found that both PINK1 transmembrane and kinase domain are important for
membrane tethering and cytosolic-facing topology. We also showed that PINK1 dual subcellular distribution
requires both Hsp90 interaction with the kinase domain and the proteolysis at a cleavage site downstream of the
transmembrane domain because removal of this cleavage site completely abolished cytosolic PINK1. In addition,
the disruption of the Hsp90-PINK1 interaction increased mitochondrial PINK1 level.
Conclusion: Together, we believe that once PINK1 enters the mitochondria, PINK1 adopts a tethered topology
because the transmembrane domain and the kinase domain prevent PINK1 forward movement into the
mitochondria. Subsequent proteolysis downstream of the transmembrane domain then releases PINK1 for
retrograde movement while PINK1 kinase domain interacts with Hsp90 chaperone. The significance of this dual
localization could mean that PINK1 has compartmental-specific functions.
Background
Nuclear-encoded mitochondrial proteins synthesized in
the cytosol are targeted to the mitochondria by one of
two types of targeting signals, a hydrophobic prese-
quence (MLS) and/or a cryptic internal sequence [1].
The MLS directs the precursor protein to the translo-
case of the outer membrane (TOMM) where transloca-
tion begins. In addition, the MLS affects the precursor
import efficiency as determined by the length of signal
peptide [2] and encodes the submitochondrial localiza-
tion of mitochondrial proteins after mitochondrial pro-
cessing, as exemplified by the presence of a cleavable or
non-cleavable stop-transfer signal [3]. Redistribution
after mitochondrial processing can also be affected by
protein folding, even though most precursor transloca-
tion requires unfolding. Of the two reported examples
of protein folding affecting mitochondrial import, the
propeller domain of PP2A/Bb2 subunit arrests the
import process and becomes on OMM protein [4]
whereas rapid folding of yeast fumarase during the
import favors the retrograde movement for a cytosolic
localization [5]. Interestingly, there are only a handful of
proteins that distribute between the mitochondria and
cytosol in a constitutive manner, fumarase being the
most studied example. It has been demonstrated that
fumarase has a 30%/70% mitochondria/cytosol isopro-
tein distribution and this dual localization occurs after
mitochondrial processing [6].
The PINK1 gene encodes a kinase protein that con-
tains an N-terminal MLS and mutations in PINK1 are
linked to a recessive form of Parkinson’s disease. Using
a heterologous expression system, varying lengths of
PINK1 MLS were tested (1-33aa, 1-77aa, and 1-156aa)
and all PINK1 MLS-GFP fusion proteins co-localized
with mitochondrial markers, such as mitotracker or
TOM20 fluorescence [7-9]. These studies proved that
PINK1 MLS is sufficient for mitochondrial targeting.
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chemical fractionation, shows that all forms of PINK1
are found at the outer membrane, intermembrane space,
and inner membrane, but not the matrix [8,10]. How-
ever, the subcellular localization of endogenous and
overexpressed PINK1 in cell culture models show that
PINK1 does not solely localize to the mitochondrial
fraction, as cytosolic and microsomal fractions are found
to contain all cleaved forms of PINK1 [7,11-13]. Overex-
pression of cytosolic PINK1, one that lacks the MLS,
exhibits protective function against MPTP toxicity in
mice and in cell culture [14]. Also, proteins found to
associate with PINK1 are either cytosolic (Parkin, DJ-1,
Hsp90, and Cdc37 [12,13,15,16]) or cytosolically exposed
(Miro and Milton [17]). Only HtrA2 and TRAP1 are
found to associate with PINK1 in the mitochondria
[10,18]. Currently no studies have examined the func-
tion of the mitochondrial form of PINK1 in the absence
of the cytosolic PINK1.
Several important questions arise from PINK1 dual
localization: what purpose does the PINK1 MLS serve if
a functional PINK1 protein is also found in the cytosol?
How does PINK1 redistribute after mitochondrial pro-
cessing? Is the function of PINK1 different in mitochon-
dria as compared to the cytosol? We are very interested
to understand the mechanism behind PINK1 dual distri-
bution, especially given the evidence that the mitochon-
drial pool of PINK1 is tethered to the OMM (with the
kinase domain exposed to the cytosol) and removal of
the PINK1 transmembrane domain mislocalizes PINK1
inside the mitochondria [19]. We previously showed
that PINK1 cleaved forms are generated from the mito-
chondrial processing of PINK1 precursor, thus suggest-
ing that PINK1 cytosolic redistribution occurs after
cleavage [12]. We hypothesize that while the PINK1
MLS can direct proteins to the mitochondria, the
required interaction between the PINK1 kinase domain
and Hsp90 chaperone favors a retrograde movement,
thus resulting in a cytosolic localization. To test our
hypothesis, we fused wildtype PINK1 as well as PINK1
mutant that lacks Hsp90 chaperone interaction with
other known MLS and examined the cytosolic and mito-
chondrial distribution of these proteins when expressed
in a cell culture model.
Results
PINK1 N-terminal cleavages occur before and after PINK1
transmembrane domain
At first glance, PINK1 MLS is similar either to those of
inner membrane (uncleaved transmembrane anchor) or
intermembrane space proteins (bipartite presequence).
The difference between these two signals is the cleavage
site after the transmembrane domain, which would
determine whether or not the protein is anchored.
Overexpression of WT PINK1 in cell lines leads to the
generation of three or more PINK1 forms, suggesting
t h ep r e s e n c eo fm u l t i p l ec l e a v a g es i t e s[ 7 , 9 , 1 1 , 1 2 ] .T h e
pattern of endogenous PINK1 protein is debatable due
to low endogenous PINK1 expression and the lack of a
high affinity antibody although it is generally accepted
a n da g r e e du p o nt h a ta tl e a s tt w oe n d o g e n o u sP I N K 1
bands are detectable-the full length and a cleaved form
around 55 kDa [13,20,21]. A most recent paper showed
three endogenous bands [21]. We and others have pre-
viously demonstrated that endogenous PINK1 behaves
similarly to the overexpressed PINK1 counterparts in
that PINK1 FL accumulates under valinomycin treat-
ment and PINK1 Δ1a n dΔ2 accumulate under protea-
some inhibitor treatment [9,12,22]. Using these two
chemical inhibitors, we first wanted to establish that
Hela cells express three forms of endogenous PINK1.
We observed that valinomycin treatment led to the
increase of PINK1 FL, and epoxomicin treatment
increased two lower protein bands when compared to
untreated cells (Figure 1A). With epoxomicin, the heav-
ily accumulated protein is PINK1 Δ1a n dt h ep r o t e i n
around 45 kDa is the PINK1 Δ2 form. We also tested
the specificity of these three PINK1 bands by using
siRNA to knockdown endogenous PINK1. In two inde-
pendent siPINK1 transfections, western blot showed
all three endogenous PINK1 proteins were decreased
(Figure 1A’), confirming the hypothesis that endogenous
PINK1 also expresses two cleaved forms. In addition, we
do not believe that the PINK1 Δ2 form is a mere degra-
dation product because our previous metabolic labeling
data showed that PINK1 Δ2 form is most stable protein
of all PINK1 forms [12].
Potential mitochondrial processing motifs have been
examined for PINK1 MLS, where one predicted site is
mapped at amino acid 35 and the second site around
amino acids 77 [8]. Both predicted cleavage sites corre-
spond with the consensus R-2 or R-10 matrix processing
motif [23]. The second processing consensus motif is
upstream of the PINK1 transmembrane domain (pre-
dicted from amino acids 90-110) and proteolysis at this
site can generate a protein with similar molecular
weight to PINK1 Δ1 form. We were first interested in
determining the approximate molecular sizes of each
PINK1 cleaved products, which might yield clues about
possible proteolytic sites. We constructed and expressed
N-terminal serial truncation mutants, Δ35 PINK1, Δ70
PINK1, Δ105 PINK1, and Δ151 PINK1. By western blot,
Δ70 and Δ105 PINK1 showed proteins expressed as
similar molecular weight as WT PINK1 Δ1a n dΔ2
cleaved products (Figure 1C). We also observed that
Δ151 PINK1 was only expressed as a single form, corre-
sponding to the smallest band in all of the PINK1 con-
structs (Figure 1C). Data from these truncation mutants
Lin and Kang BMC Cell Biology 2010, 11:90
http://www.biomedcentral.com/1471-2121/11/90
Page 2 of 12Figure 1 Design and expression of various PINK1 constructs. A) Three endogenous PINK1 forms can be detected and identified in Hela cells
using the Odyssey Infrared Imaging. Valinomycin (Δψm dissipater) increases PINK1 FL, epoxomicin (proteasome inhibitor) increases both PINK1
Δ1 and Δ2. A’) PINK1 siRNA knocked down all three endogenous PINK1 forms. Asterisk denotes non-specific band from a-PINK1 antibodies. B)
Schematic diagram of various PINK1 deletion mutants and various MLS-PINK1 fusion constructs. Cyt b2 is yeast cytochrome b2 MLS from 1-33
amino acids. IMMT is human mitofilin MLS from 1-187 amino acids. C) Protein expression of aforementioned PINK1 constructs relative to WT
PINK1 is compared by anti-FLAG western blot. All PINK1 deletion mutants express PINK1 Δ2 form, corresponding to Δ151 PINK1 molecular
weight. Immt-Δ151 PINK1 is detected as a single protein product.
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and aa105-151. This is similar to a recent publication
using serial N-terminal deletion PINK1 constructs
which suggested that the first cleavage site resides
between aa91-101 [19], placing the putative cleavage site
within the transmembrane domain. Since the disruption
of N-terminal sequences may have affected mitochon-
drial targeting and cleavage, we also studied internal
deletion mutants to map out the proteolytic sites in the
PINK1 MLS (Figure 1B). By targeting the predicted clea-
vage sites in the PINK1 N-terminus, we truncated from
aa25-40, aa66-80, aa66-90, aa90-110, and aa130-150.
Unfortunately none of the internal deletions were able
to abolish PINK1 cleavage (Figure 1C), illustrating the
complexity of PINK1 MLS proteolysis. We did find that
Δ25-40 PINK1 was consistent with Δ35 PINK1 in ruling
out the cleavage site predicted at position 35. Based on
N-terminal deletion mutants we predicted that a second
cleavage site resides downstream of the transmembrane
domain.
PINK1 transmembrane and kinase domain determine
PINK1 subcellular distribution
As demonstrated before, WT PINK1 overexpression
showed dual subcellular distribution with all three forms
found in both mitochondrial and cytosolic fractions
(Figure 2A). We asked how elements in the PINK1
structure can contribute to the mechanism behind
PINK1 dual distribution. PINK1 protein contains three
easily identifiable elements, an N-terminal MLS, a TM,
and a C-terminal kinase domain. In general, the pre-
sence of a transmembrane domain in the MLS serves as
a stop-transfer, or sorting signal, that prevents mito-
chondrial proteins from matrix import. We tested three
most feasable hypotheses: 1) PINK1 TM serves as a stop-
transfer signal, given that PINK1 is not found in the
matrix and PINK1 mislocalized to the matrix compart-
ment when the TM was deleted [19], 2) the cleavage
after the transmembrane domain allows mitochondrial
pool of PINK1 to become soluble, thus making it possible
to redistribute to the cytosol, 3) the kinase domain inter-
action with Hsp90 in the cytosol prevents PINK1 from
complete mitochondrial import, thus PINK1 adopts a
topology where the kinase domain is exposed to the cyto-
solic face on the OMM.
We first tested the involvement of the TM in topology
and dual distribution by using PINK1 MLS-GFP, where
the PINK1 TM is intact but the C-terminal kinase
domain is now replaced with GFP. We found that
PINK1 MLS-GFP distributed only to the mitochondria
and not the cytosol (Figure 2B and 3). This GFP fusion
protein was protected from proteinase K digest, suggest-
ing that it is likely localized inside the outer membrane
(Figure 2B). As a control, we examined the mito-GFP
protein by fractionation, using the cytochrome b2 MLS
(1-33 aa). Mito-GFP also resisted proteinase K digest
and was not found in the cytosol (Figure 2C). Com-
bined, the data suggests the TM alone is not enough to
lead to PINK1 topology with C-terminal portion of the
protein facing the cytosol or cytosolic redistribution.
Next we examined our earlier hypothesis that the clea-
vage after the transmembrane domain allows tethered
mitochondrial PINK1 to become cytosolic. Because we
are unable to abolish the second PINK1 cleavage with
our internal deletion mutants, we constructed and
expressed Immt-Δ151 PINK1 fusion protein, one that
contains the mitofilin MLS and the PINK1 kinase
domain (Figure 1). Mitofilin is a mitochondrial inner
membrane protein whose MLS includes a classical pre-
sequence followed by a TM, but not a proteolytic site
downstream of the TM [24]. We found Immt-Δ151
PINK1 protein localized solely to the mitochondria and
its sensitivity to proteinase K suggests an outer mem-
brane topology (Figure 2D and 3). We reasoned that the
lack of proteolysis after the TM prevents the release of
Immt-Δ151 PINK1 from the mitochondria and it is very
likely that Immt-Δ151 PINK1 is tethered to the outer
membrane, similar to WT PINK1. The Immt-Δ151
PINK1 construct represents the first successful demon-
stration that we are able to eliminate the cytosolic pool
of PINK1 while retain proper PINK1 mitochondrial
topology.
We then asked whether the PINK1 kinase domain
itself can confer tethered topology and cytosolic distri-
bution. This time we deleted PINK1 MLS and fused
cytochrome b2 MLS to the kinase domain. When we
expressed mito-Δ151 PINK1, which now lacks a TM but
retains the C-terminal kinase domain, we found this
protein distributed equally to the cytosol and the mito-
chondria. The mitochondrial fraction of mito-Δ151
PINK1 was protected from proteinase K digest, similar
to matrix chaperone Hsp60 (Figure 2E and 3). We also
examined the subcellular distribution of Δ90-110
PINK1, where the PINK1 TM is deleted. We found that
Δ90-110 PINK1 predominantly localized to the mito-
chondrial fraction that is insensitive to proteinase treat-
ment and a small fraction of cleaved Δ90-110 PINK1
was found in the cytosolic fraction (Figure 2F). Thus in
the absence of a transmembrane domain, PINK1 has
altered submitochondrial localization but some cytosolic
redistribution remains. Taken all together, our data sug-
gests that 1) the TM and the kinase domain are both
needed for a tethered, cytosolic-facing, kinase domain
topology and 2) PINK1 cytosolic redistribution requires
both proteolysis after the TM and the kinase domain.
It was previously shown that PINK1 lacking MLS is
mostly cytosolic although it can still interact with OMM
or IMS proteins [17,18]. When we expressed Δ151
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protein localized mostly to the cytosol, but some was
still found in the mitochondrial fraction and co-localized
with mitochondrial markers (Figure 2G and 3). It is
likely that Δ151 PINK1 contains additional internal
cryptic targeting signal because mitochondrially-loca-
lized Δ151 PINK1 was protected from proteinase K
digest. Finally, we asked whether or not PINK1 dual dis-
tribution is evolutionarily conserved by examining the
subcellular localization of drosophila PINK1. We found
drosophila PINK1 in both cytosolic and mitochondrial
fractions with two cleavage sites similar to the mamma-
lian form (Figure 2H).
To further examine the idea that PINK1 kinase
domain-Hsp90 interaction modulates mitochondrial
e n t r yo fP I N K 1 ,w eh y p o t h e s i zed that destabilizing the
PINK1-Hsp90 interaction will increase PINK1 import
into the mitochondria. We wanted to test the idea that
the Hsp90 interaction is preventing PINK1 forward
movement during mitochondrial import. We chose to
use the PINK1 L347P mutation, a naturally occurring
PD mutation with reduced Hsp90 interaction [13,25].
First we compared the subcellular localization between
PINK1 WT and PINK1 L347P and found there was not
observable difference in the cytosolic or mitochondrial
distribution between the two proteins (Figure 4A). Even
with a loss of Hsp90 binding, we reasoned that the
intact transmembrane domain was enough to prevent
PINK1 L347P from completely entering the mitochon-
dria. Therefore, we constructed and expressed mito-
Figure 2 Subcellular distribution of various PINK1 mutants in Hela cells by fractionation. A) PINK1 MLS-GFP localizes to the mitochondria
and is partially sensitive to proteinase K digestion. B) mito-GFP localizes to the mitochondria and is not digested by proteinase K. C)
Overexpression of wildtype PINK1-flag displays dual localization for all forms of PINK1. D) Immt-Δ151 PINK1 localizes to the mitochondria and is
sensitive to proteinase K digestion. E) mito-Δ151 PINK1 localizes equally in both cytosol and mitochondria, where the mitochondria fraction is
not digested by proteinase K. F) Δ90-110 PINK1 mostly localizes to mitochondrial fraction with a small portion of cleaved form redistributed to
the cytosolic fraction. G) Δ151 PINK1 localizes mainly in the cytosol with a small pool in the mitochondria. H) Drosophila PINK1-flag (DmPINK1)
transfected in Hela cells also distributed to both cytosolic and mitochondrial fractions, similar to human PINK1. ATP5A, the a-subunit of ATP
synthase, marks the mitochondria. p38 MAPK marks the cytosol.
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that of cytochrome b2 (1-33aa) to isolate the effect of
TM out of the equation and to focus on Hsp90 interac-
tion (Figure 4B). We compared the subcellular distribu-
tion of mito-Δ151 PINK1 in the absence and presence
of Hsp90 inhibitor, 17-AAG (Figure 4B). We observed
that in the presence of 17-AAG, mito-Δ151 PINK1 loses
its cytosolic distribution with slight reduction in mito-
chondrial PINK1. We also noticed that the PINK1 pro-
tein sizes are slightly different between cytosol and
mitochondria, although we are unsure of the explana-
tion behind this size shift. It has been reported that
matrix-localized PINK1 appears as a doublet either
through post-translational modification or this size dif-
ference may arise from PINK1 having entered the mito-
chondria to have its MLS cleaved off by mitochondrial
matrix protease [19]. In addition to the Hsp90 inhibitor
experiment, we constructed mito-L347P PINK1 and
compared its subcellular distribution to mito-Δ151
PINK1. When we compared the cytosol/mitochondria
distribution between mito-Δ151 PINK1 and mito-L347P
PINK1, there was significantly more (p = 0.025) mito-
L347P PINK1 (1.226 ± 0.086, mean ± SEM, n = 3) than
mito-Δ151 PINK1 (0.888 ± 0.044, mean ± SEM, n = 3)
in the mitochondria (Figure 4D-E). Lastly, we confirmed
the Hsp90 interaction by co-immunoprecipitation and
found a reduction in Hsp90 binding with mito-L347P
PINK1 compared to Δ151 or mito-Δ151 PINK1 (Figure
4F). Full length L347P PINK1 also interacted less with
Hsp90 compared to WT PINK1, and none of the GFP
fusion proteins associated with Hsp90 (Figure 4F).
These data suggest that the Hsp90 chaperone interac-
tion on the cytosolic side can prevent PINK1 from
further mitochondrial entry, consequentially leading to
t h er e l e a s eo fP I N K 1f r o mt h em i t o c h o n d r i ao n c ep r o -
teolysis removes PINK1 from the transmembrane
anchor.
Discussion
As mentioned in the Introduction, both cytosolic and
mitochondrial functions of PINK1 have been suggested.
Elucidating the exact PINK1 subcellular localization will
help us to understand these reported functions. The dis-
tribution of PINK1 in cells suggests that while a small
percentage of PINK1 can be fully imported or associated
with the mitochondria, the majority of PINK1 is
Figure 3 Immunofluorescence of PINK1-MLS GFP, Δ151 PINK1, mito-Δ151 PINK1, and Immt-Δ151 PINK1 in Hela cells. Cells transiently
transfected with aforementioned constructs are also co-stained with either cytosol marker Hsp90 or mitochondria marker COX IV. Confocal
images are analyzed with ImageJ and the yellow color in the overlay panels represents co-localization. Scale bar = 5 μm.
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PINK1 contains a functional MLS and localizes within
the mitochondria supports the hypothesis that PINK1
has a functional role in the mitochondria. While this
functional role is unclear, several studies suggest a role
of PINK1 in the mitochondrial fission/fusion pathway
[26-28] and in mitophagy of damaged mitochondria
[22,29-32]. Other compelling scientific data supports the
hypothesis that PINK1 is also a cytosolic kinase. Strong
evidence of a cytosolic degradation, cytosolic binding
partners, and a protective function in the cytosol all
point to a kinase protein with a dual localization and
possibly two different functions, depending on the sub-
cellular compartment. A major limitation in understand-
ing the subcellular localization of PINK1 is the fact that
many studies on PINK1 rely on PINK1 overexpression.
Two challenges force researchers to utilize a heterolo-
gous overexpression system: the lack of a specific multi-
purpose antibody against PINK1 (the anti-PINK1 anti-
bodies are only good for Western blot analysis) and the
fact that the endogenous PINK1 expression level is very
low. As we have demonstrated previously [12], proper-
ties of exogenous PINK1 are reflected by the endogen-
ous PINK1, justifying that overexpressed PINK1 serves
as a good model for the endogenous protein.
Unlike other mitochondrial proteins that localize
exclusively to the mitochondria, mitochondrial proteins
that adopt a cytosolic localization do so in a stimulus-
induced fashion. With the exception of yeast fumarase
and human PINK1, no other single gene-encoded,
Figure 4 Hsp90 interaction affects PINK1 subcellular distribution in Hela cells. A) Subcellular distribution of WT and L347P PINK1 in Hela
cells is not noticeably different. C = cytosolic fraction; M = mitochondrial fraction. B) Subcellular distribution of mito-Δ151 PINK1 shows the loss
of cytosolic PINK1 when cells are treated with 1 μM 17-AAG, a Hsp90 inhibitor, for 4 hours. C) mito-L347P PINK1 localizes to cytosol and
mitochondria. D) Mito-L347P PINK1 accumulates more in the mitochondria than mito-Δ151 PINK1, with little change to the cytosol distribution.
E) Quantification from three independent experiments showing more PINK1 in mitochondrial fraction with L347P mutation. P = 0.025. Increase in
PINK1 in the cytosolic fraction with L347P is not statistically significant. Mean ± SEM, n = 3. Statistical significance was calculated with ANOVA
and Fisher’s PLSD post-hoc test. F) L347P mutation reduces PINK1 interaction with Hsp90 by co-immunoprecipitation. GFP does not co-
immunoprecipitate with Hsp90. G) Summary diagram depicting PINK1 protein structures and the role of each component in PINK1 topology and
subcellular distribution. See Discussion for more details.
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the mitochondria and the cytosol, with the majority of
the isoprotein residing in the cytosol. (At least we have
not detected others so far.) In this paper, we investi-
gated the important factors for PINK1 topology and
dual localization and found three necessary components
in the PINK1 protein-the transmembrane domain, the
cleavage site after the TM, and the Hsp90 interaction
(Figure 4G). We confirmed that the PINK1 MLS is
responsible for mitochondrial localization and that two
cleavage sites in the PINK1 MLS are responsible for
generating PINK1 Δ1a n dΔ2, present in both endogen-
ous and exogenous PINK1. We attempted to map out
the proteolytic sites by deleting the protein sequence
encompassing the predicted cleavage sites. However,
PINK1 continued to be cleaved into two products from
the precursor. This could mean that we did not target
the correct cleavage sites even though they are predicted
by MitoPort or other prediction programs. PINK1 prese-
quence cleavage might not follow the classical R-2/R-3/
R-10 motif, where there are numerous examples [23,33].
Alternatively, it is thought that cleavage specificity of
mitochondrial peptidases is less dependent on the pri-
mary protein sequence and more on the structural ele-
ments present in both the presequence as well as the
mature protein [33]. Thus mutational or deletion studies
(as we have done) will have variable results, including a
lack of obvious effect on presequence cleavage. What is
clear from our internal deletion study is that a second
cleavage site is present after the transmembrane domain
and this site plays an important role in PINK1 subcellu-
lar redistribution. Removal of this second cleavage site
completely abolished cytosolic distribution of PINK1, as
we showed with a noncleavable TM in mitofilin MLS.
Because we are unable to abolish the cleavage of PINK1
MLS, we took advantage of the similarity between
PINK1 MLS and mitofilin MLS to determine how prese-
quence cleavage plays a role in PINK1 topology and dis-
tribution. Even though Immt-Δ151 PINK1 was not
found in cytosol, it was digested by proteinase K, similar
to WT PINK1, suggesting that it is tethered to the outer
surface of the mitochondria. We predict that if we sub-
stitute the PINK1 MLS with a bipartite presequence of
an intermembrane space protein (ie cytochrome b2 [3])
then PINK1 would become soluble and redistribute to
the cytosol.
When we addressed the role of the transmembrane
domain, we confirmed the previous hypothesis that the
transmembrane domain, acting as a stop-transfer signal,
prevents forward import of PINK1 into the matrix. We
demonstrated that in the absence of a transmembrane
domain, either by deleting the PINK1 TM or by substi-
tuting PINK1 MLS with a matrix targeting signal, we
were able to redirect mitochondrial PINK1 into
proteinase-insensitive fraction. Thus the transmembrane
domain is important, although not sufficient, for mem-
brane tethering and cytosolic-facing topology.
We found that the PINK1 kinase domain, in conjunc-
tion with presequence cleavage, contributes to cytosolic
redistribution of PINK1. Mitochondrial-targeted GFP
(MLS-GFP and PINK1 MLS-GFP) were not found in
the cytosol nor was GFP co-immunoprecipitated with
Hsp90. When PINK1 kinase domain was present and
co-immunoprecipitated with Hsp90, these recombinant
proteins all showed dual subcellular distribution, except
for IMMT-Δ151 PINK1 (as discussed previously). When
we introduced natural PINK1 mutation L347P in the
kinase domain, we not only disrupted the Hsp90-PINK1
interaction, we increased the mitochondrial PINK1 level,
provided that a TM is absent. More PINK1 L347P
mutant protein was found in the mitochondrial fraction
compared to its wildtype counterpart. To explain why
L347P PINK1 and mito-L347P PINK1 are found in the
cytosol, we believe that a complete loss of Hsp90 inter-
action is necessary, as demonstrated by GFP proteins. In
our co-immunoprecipitation experiment, L347P PINK1
and mito-L347P PINK1 showed significant reduction
but not a 100% loss of Hsp90 interaction. This residual
Hsp90 binding may account for the cytosolic redistribu-
tion. Of course, to completely eliminate PINK1-Hsp90
interaction will render PINK1 unstable and destine for
rapid proteasome degradation. Importantly, we want to
point out that decreased PINK1 retention in the cytosol
consists of both accelerated degradation and increased
PINK1 mitochondrial entry. When Hsp90 inhibitor,
17-AAG, was used in the experiment for Figure 4B, we
did not see an increase in total mitochondrial PINK1
comparing untreated to 17-AAG-we actually saw a loss
of signal. This is probably due to accelerated degrada-
tion and the loss of total PINK1. Thus we chose to
complement the inhibitor data with the L347P mutation
experiment-to avoid accelerating PINK1 degradation
and other non-specific effects from 17-AAG, thereby to
focus on how L347P mutation influences subcellular dis-
tribution. In that setting, mitochondrial PINK1
increased. Together, we believe that once PINK1 enters
the mitochondria, PINK1 adopts a tethered topology
because both the transmembrane domain and the kinase
domain prevent PINK1 forward movement into the
mitochondria. Subsequent proteolysis downstream of
the transmembrane domain then releases PINK1 for ret-
rograde movement while PINK1 kinase interacts with
the Hsp90 chaperone.
As demonstrated by Zhou et al (2008), we find that
PINK1 TM is required for kinase domain facing the cyto-
sol. In addition, PINK1 kinase domain facing the cytosol
also requires Hsp90 interaction and we believe it is the
combined effects of TM and chaperone interaction that
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demonstrated that PINK1 Δ2 lacks the TM domain and
thus its association with mitochondria must be through
another mechanism. The question turns to whether or
not PINK1 Δ1 is tethered to the mitochondrial mem-
brane? We already know that this PINK1 cleaved form is
rapidly degraded by the proteasome. Given the evidence
that the first cleavage site might reside within the TM
region, this suggests that PINK1 Δ1 might be loosely
anchored or not anchored at all in its transient half-life.
Conclusions
In conclusion, the interaction of the kinase domain with
Hsp90 plays a significant role in PINK1 topology and
cytosolic redistribution. It is conceivable that Hsp90
binding to the PINK1 kinase domain is preventing the
vectorial movement of PINK1 precursor protein during
t h ee n t i r ei m p o r tp r o c e s s .W h i l eP I N K 1i st a r g e t e dt o
the mitochondria, PINK1 function in the mitochondria
is unclear. Published results show that loss of PINK1
can lead to mitochondrial dysfunction, but it is not clear
that this is the result of losing mitochondrial PINK1 or
cytosolic PINK1. Echoing a concern previously raised by
Beilina et al (2005), the possibility that the cytosol con-
tains mature PINK1 kinase challenges researchers to
delineate how exactly PINK1 function links directly to
mitochondrial functions. Embedded in this dual subcel-
lular localization model is the proposal that PINK1 has
compartment-specific functions, as was found for yeast
fumarase. We believe that functional studies of PINK1
need to implement the experimental design of examin-
ing PINK1 function when it resides in only one subcel-
lular compartment in order to tease apart PINK1
functional roles.
Methods
cDNAs
Mutant PINK1 cDNAs were amplified from wildtype
human PINK1 cDNA via PCR-driven overlap extension
[34] with the following primer pairs. The PCR product
was then cloned into p3XFLAG-CMV14 (Sigma) flanked
by EcoRI and BamHI restriction enzyme sites. Δ25-40
PINK1 (Forward 5’ TTC ACG GGC AAG GTC CGC
GGA GAG CGT 3’;Reverse 5’ACG CTC TCC GCG GAC
CTT GCC CGT GAA 3’), Δ66-80 PINK1 (Forward 5’
CTC GGG CTC CCT AAC TTG CAG CGG CAG TTC
3’; Reverse 5’ GAA CTG CCG CTG CAA GTT AGG
GAG CCC GAG 3’), Δ66-90 PINK1 (Forward 5’ CTC
G G GC T CC C TA A CG G CT G CG C GG G CC C TT3 ’;
Reverse 5’ AAG GGC CCG CGC AGC CGT TAG GGA
GCC CGA G 3’), Δ90-110 PINK1 (Forward 5’ GTG
GTG CGG GCC ATC GAG GAA AAA CAG 3’; Reverse
5’ CTG TTT TTC CTC GAT GGC CCG CAC CAC 3’),
Δ130-150 PINK1 (Forward 5’ GTC AGG AGA TCC
AGT TTC GGC TGG AGG 3’; Reverse 5’ CCT CCA
GCC GAA ACT GGA TCT CCT GAC 3’),Δ151 PINK1
(Forward 5’ ATT GAA TTC AAT GCG GCT GGA GGA
GTA TCT G 3’; Reverse 5’ ATA GGA TTA CAG GGC
TGC CCT CCA TGA 3’), L347P PINK1 (Forward 5’CTG
CTG CAG CTG CCG GAA GGC GTG GAC 3’;Reverse
5’ GTC CAC GCC TTC CGG CAG CTG CAG CAG 3’).
Drosophila PINK1 was cloned from Drosophila Gene
Collection Clone GH20931 (Open Biosystems) with
PCR (Forward 5’ CAG AAG CTT ATG TCT GTG AGA
CTG CTG AC 3’; Reverse 5’ CAG GAT ATC AGC GCC
ACC ACA TTC TGG A 3’)
The starting ATG of GFP cDNA in pAcGFP-N1 plas-
mid (Clontech) was remove by PCR (Forward 5’ CTT
GGG ATC CAG TGA GCA AGG GCG CCG A 3’;
Reverse 5’ GTC GCG GCC GCT CAC TTG TAC AGC
TCA T 3’) and GFP was cloned back into the plasmid in
BamHI and NotI sites; renamed plasmid GFP-ΔATG.
Mito-GFP was cloned by ligating annealed phosphory-
lated oligos of cytochrome b2 MLS into the EcoRI and
BamHI site of GFP-ΔATG (Forward 5’ phospho/AAT
TCA TGC TAA AAT ACA AAC CTT TAC TAA AAA
TCT CGA AGA ACT GTG AGG CTG CTA TCC TCA
G A GC G TC T AA G AC T AG A TT G AA C AC A AT C C
GCG CGT ACG GTT CTA CG 3’;R e v e r s e5 ’ phospho/
GAT CCG TAG AAC CGT ACG CGC GGA TTG TGT
TCA ATC TAG TCT TAG ACG CTC TGA GGA TAG
CAG CCT CAC AGT TCT TCG AGA TTT TTA GTA
AAG GTT TGT ATT TTA GCA TG 3’). To generate
PINK1 MLS-GFP, PINK1 MLS was PCR amplified from
WT PINK1 cDNA and cloned in the EcoRI and BamHI
sites of GFP-ΔATG by PCR (Forward 5’ AAG AT TCA
ATG GCG GTG CGA CAG GCG 3’; Reverse 5’ ACT
GGA TCC CGA AAG CCC TGC AAG C 3’). To gener-
ate mito-Δ151 PINK1, Δ151-flag was cloned into EcoRI
and NotI of GFP-ΔATG by PCR amplifying Δ151
PINK1 (Forward 5’ ATT GAA TTC CGG CTG GAG
GAG TAT CTG 3’; Reverse 5’ ATT GCG GCC GCT
CAC TAC TTG TCA TCG TCA T 3’). Then cyt b2 MLS
was cloned into XhoI and EcoRI sites by PCR amplifying
mito-GFP as template (Forward 5’ ACC CTC GAG ATG
CTA AAA TAC AAA CCT TTA C 3’;R e v e r s e5 ’ AAA
GAA TTC GGT AGA ACC GTA CGC GCG G 3’). To
generate Immt-Δ151 PINK1, Immt MLS was PCR
amplified and cloned into XhoI and EcoRI sites to
replace cyt b2 MLS in mito-Δ151 PINK1 (Forward 5’
AAA CTC GAG ATG CTG CGG GCC TGT C 3’;
Reverse 5’ AAT GAA TTC TGA AAG TGC AGG TGT
GG 3’). All plasmids were sequence verified. For PINK1
knockdown, siPINK1 oligos (Sense 5’ GGA GAU CCA
GGC AAU UUU UU 3’;A n t i s e n s e5 ’ AAA AAU UGC
CUG GAU CUC C 3’) were purchased from Applied
Biosystems/Ambion. Silencer Negative Control #1
siRNA from Applied Biosystems/Ambion was used as
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fected into Hela cells for three consecutive days with
siPORT Amine Transfection Agent (Applied Biosys-
tems/Ambion) according to manufacture protocol.
Cell Culture and Transfection
Hela CCL-2 cells were purchased from ATCC and cul-
tured in DMEM complete media supplemented with
10% FBS and 1% penicillin/streptomycin. Transient
transfection method with Lipofectamine 2000 was per-
formed according to manufacturer’sp r o t o c o l( I n v i t r o -
gen). Briefly, Hela CCL-2 cells were plated onto 60 mm
2
tissue culture dishes at 90% confluency at the time of
transfection. 2 μg of cDNA was diluted in 250 μL
OPTI-MEM. 5 μL of Lipofectamine 2000 was diluted in
250 μL of OPTI-MEM. The mixture of cDNA and Lipo-
fectamine 2000 was added to cells in OPTI-MEM. The
transfection media was replaced by DMEM growth
media six hours after transfection. Cells were subjected
to experiments 48 hours following transfection.
Co-Immunoprecipitation
Co-IP experiments followed the methods described pre-
viously [35]. Briefly, cells were lysed in 1% Triton X-100
buffer (20 mM HEPES [pH 7.5], 150 mM NaCl, 1% Tri-
ton X-100, 10% glycerol, 1 mM EDTA, protease inhibi-
tor cocktail, and PMSF). Lysates were rotated for 1 hr at
4°C then cleared by centrifugation at 13,000 g for 10
min at 4°C. Equal protein amount was used for co-IP
for all samples. Rabbit anti-FLAG (1:100) or anti-GFP
(1:100) antibodies were used for immunoprecipitation at
4°C overnight. 30 μL of Protein A/G PLUS agarose was
added the next day, washed three times in 1% Triton X-
100 buffer, and resuspended in 2× sample buffer for
SDS-HEPES PAGE (Pierce).
Mitochondrial Isolation
Mitochondria were isolated from Hela CCL-2 cells
according to manufacturer’s protocol (Pierce) with
minor modifications. Briefly, the cells were trypsinized
and harvested. A Dounce homogenizer was used to lyse
the cells by 70 strokes. After removing the nuclear frac-
tion, the crude supernatant was spun at 3,000 g for 20
minutes to pellet the intact mitochondria. The mito-
chondrial pellet was resuspended in IP buffer (150 mM
NaCl, 50 mM Tris-HCl, 0.5% NP-40, 0.5% sodium deox-
ycholate, 5 mM EDTA, 0.25% SDS, 0.25 mM PMSF and
protease inhibitor cocktail) to collect mitochondrial pro-
teins. For each fractionation, equal amounts of soluble
cytosolic protein and mitochondrial protein were deter-
mined by BCA assay (Pierce). Proteins were resolved on
SDS-HEPES PAGE.
Proteinase K proteolysis assay
Mitochondria were isolated by the mitochondrial isola-
tion protocol described above. The mitochondrial pellet
was resuspended in import buffer (0.6 M sorbitol, 50
mM HEPES, 50 mM KCl, 10 mM MgCl2,2m M
KH2PO4,p H7 . 0w i t hK O H )a n da l i q u o t e di n t ot h r e e
equal fractions. Final concentration of 50 μg/mL of pro-
teinase K (Qiagen) was added to the appropriate sample
tube with or without a final concentration of 1% Triton
X-100. Samples were incubated on ice for 30 minutes
and the proteolysis was inhibited by the addition of
PMSF and protease inhibitor cocktail. Then the samples
were centrifuged at max speed for 5 minutes and the
pellet was resuspended in IP buffer. Proteins were
resolved on SDS-HEPES PAGE.
Immunocytochemistry
Transfected Hela CCL-2 cells were fixed in paraformal-
dehyde (4% for 10 min at room temperature) and then
washed three times in 0.1% Triton X-100. Antigen retrie-
val was performed by incubating coverslips in 50 mM
Tris-buffered saline, pH 7.5, at 95°C for 20 min, followed
by three washes in PBS. Nonspecific immunoreactivity
was blocked with 10% goat serum. Cultures were incu-
bated overnight at 4°C in PBS containing a polyclonal
FLAG (1:250 dilution) antibody and a monoclonal CoxIV
or Hsp90 (1:250 dilution) antibody. Immunoreactivity to
FLAG was amplified and detected using an Alexa 488
conjugate of a goat anti-rabbit IgG antibody and CoxIV
and Hsp90 were amplified with Alexa 563 conjugate of a
goat anti-mouse IgG antibody. The cells were imaged
using a 150×, 1.35 NA objective, and optical slices
through the cultures were obtained using the 488 and
543 nm lines, respectively, of an Olympus DSU “fixed
cell” Spinning Disk Confocal Microscope (Tokyo, Japan)
at the Integrated Microscopy Core Facility at the Univer-
sity of Chicago. Images were analyzed with ImageJ (NIH).
Western blot analysis
Protein quantification was done using the BCA method
(Pierce). Immobilon-P PVDF membrane was used in
Western blotting (Millipore). After wet transfer, mem-
brane was rinsed briefly with water. The membrane was
blocked for 2 hours in blocking buffer (1XTBS contain-
ing 5% milk, and 0.1% tween-20). Appropriate primary
antibodies were incubated for overnight in blocking buf-
fer, and secondary antibodies were incubated in room
temperature for 1 hour in blocking buffer. The mem-
brane was then developed with ECL reagents (Milipore)
a n di m a g e dw i t hC h e m i G e n i u sB i o - I m a g i n gs y s t e m
(Syngene). Optical density of protein signals were mea-
sured with ImageJ. Endogenous PINK1 was detected
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Biosciences).
Antibodies and Chemicals
The following antibodies were purchased commercially.
Anti-PINK1 (BC100-494) 1:1000 (Novus Biological),
anti-FLAG 1:100 (Sigma), anti-FLAG M2 1:5000
(Sigma), anti-Hsp90b 1:250 (Santa Cruz), anti-b actin
1:20,000 (Sigma), anti-p38 MAPK 1:2000 (Cell Signal
Technologies), anti-CoxIV 1:200 (Invitrogen), anti-
mouse IgG-HRP 1:20,000 (Promega), anti-goat IgG-HRP
1:1000 (Promega), anti-rabbit IgG HRP 1:10,000 (Pro-
mega), anti-ATP5A 1:10,000 (BD Biosciences), anti-
Hsp60 1:10,000 (Cell Signal Technologies), anti-GFP
1:10,000 (Clontech). All chemicals are from Sigma,
unless noted.
Statistical Analysis
Statistics were calculated with ANOVA followed by
Fisher’s PLSD post-hoc test for significance at 5% with
Statview software (SAS Institute, NC, USA).
Abbreviations
PINK1: PTEN-induced putative kinase 1; OMM: Outer mitochondrial
membrane; MLS: Mitochondrial localization signal; GFP: Green fluorescent
protein; FL: Full-length; TM: transmembrane; AA: amino acid.
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